Literature DB >> 17618952

Free and total leptin serum levels and soluble leptin receptors levels in two models of genetic obesity: the Prader-Willi and the Down syndromes.

Caterina Proto1, Daniela Romualdi, Rosa Maria Cento, Corrado Romano, Giuseppe Campagna, Antonio Lanzone.   

Abstract

Alterations in energy balance and feeding behavior and the subsequent high frequency of obesity are hallmarks of 2 chromosomal diseases: the Prader-Willi syndrome (PWS) and the Down syndrome (DS). Leptin, an important regulator of food intake and energy homeostasis, circulates in 2 forms: a free, therefore active, fraction and a fraction bound to the soluble leptin receptor, whose bioavailability consequently participates in the regulation of leptin action. To investigate the possible role of the free-bound leptin balance in the pathogenesis of obesity in PWS and DS, we enrolled 7 obese women with DS, 5 obese women with PWS, 7 obese women, and 7 normal-weight healthy control women. Basal hormonal concentrations, total and free leptin levels, and leptin receptors levels were measured in plasma samples obtained from the 4 groups. No significant differences were observed in the hormonal milieu. Women with DS exhibited lower total leptin concentrations (P<.01), comparable leptin receptor level and, therefore, lower free leptin values (P<.01) when compared with obese controls, then resembling the profile peculiar to normal-weight control women. At variance, subjects with PWS did not differ from obese controls regarding both leptin and leptin receptor levels. Our data suggest that, whereas subjects with PWS have a leptin assessment corresponding to their degree of obesity, subjects with DS may have a defect in the secretion of leptin that could at least partially account for this form of syndromal obesity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17618952     DOI: 10.1016/j.metabol.2007.03.016

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  15 in total

1.  Gait patterns in Prader-Willi and Down syndrome patients.

Authors:  Veronica Cimolin; Manuela Galli; Graziano Grugni; Luca Vismara; Giorgio Albertini; Chiara Rigoldi; Paolo Capodaglio
Journal:  J Neuroeng Rehabil       Date:  2010-06-21       Impact factor: 4.262

Review 2.  Role of ghrelin in the pathophysiology of eating disorders: implications for pharmacotherapy.

Authors:  Sebastian Cardona Cano; Myrte Merkestein; Karolina P Skibicka; Suzanne L Dickson; Roger A H Adan
Journal:  CNS Drugs       Date:  2012-04-01       Impact factor: 5.749

3.  Psychiatric adverse effects of rimonobant in adults with Prader Willi syndrome.

Authors:  Roja Motaghedi; Elizabeth G Lipman; Jeannette E Hogg; Paul J Christos; Maria G Vogiatzi; Moris A Angulo
Journal:  Eur J Med Genet       Date:  2010-10-20       Impact factor: 2.708

4.  Brain structural alterations in obese children with and without Prader-Willi Syndrome.

Authors:  Mingze Xu; Yi Zhang; Karen M von Deneen; Huaiqiu Zhu; Jia-Hong Gao
Journal:  Hum Brain Mapp       Date:  2017-05-23       Impact factor: 5.038

5.  Pathogenesis of adolescent idiopathic scoliosis in girls - a double neuro-osseous theory involving disharmony between two nervous systems, somatic and autonomic expressed in the spine and trunk: possible dependency on sympathetic nervous system and hormones with implications for medical therapy.

Authors:  R Geoffrey Burwell; Ranjit K Aujla; Michael P Grevitt; Peter H Dangerfield; Alan Moulton; Tabitha L Randell; Susan I Anderson
Journal:  Scoliosis       Date:  2009-10-31

6.  Effects of metformin in children and adolescents with Prader-Willi syndrome and early-onset morbid obesity: a pilot study.

Authors:  Jennifer L Miller; Tiffany D Linville; Elisabeth M Dykens
Journal:  J Pediatr Endocrinol Metab       Date:  2014-01       Impact factor: 1.634

7.  Altered inflammation, paraoxonase-1 activity and HDL physicochemical properties in obese humans with and without Prader-Willi syndrome.

Authors:  Gianna Ferretti; Tiziana Bacchetti; Simona Masciangelo; Graziano Grugni; Virginia Bicchiega
Journal:  Dis Model Mech       Date:  2012-07-19       Impact factor: 5.758

8.  Importance of reward and prefrontal circuitry in hunger and satiety: Prader-Willi syndrome vs simple obesity.

Authors:  L M Holsen; C R Savage; L E Martin; A S Bruce; R J Lepping; E Ko; W M Brooks; M G Butler; J R Zarcone; J M Goldstein
Journal:  Int J Obes (Lond)       Date:  2011-10-25       Impact factor: 5.095

Review 9.  Health promotion and disease prevention strategies in older adults with intellectual and developmental disabilities.

Authors:  Eli Carmeli; Bita Imam
Journal:  Front Public Health       Date:  2014-04-14

10.  The role of leptin, soluble leptin receptor, resistin, and insulin secretory dynamics in the pathogenesis of hypothalamic obesity in children.

Authors:  Tulay Guran; Serap Turan; Abdullah Bereket; Teoman Akcay; Goksenin Unluguzel; Firdevs Bas; Hulya Gunoz; Nurcin Saka; Ruveyde Bundak; Feyza Darendeliler; Pinar Isguven; Metin Yildiz; Erdal Adal; Sevil Sarikaya; Leyla Akin Baygin; Nihal Memioglu; Hasan Onal; Oya Ercan; Goncagul Haklar
Journal:  Eur J Pediatr       Date:  2008-11-29       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.